Press Releases

Avantor® Receives Korea Health Industry Development Institute (KHIDI) Award for Contribution of Health and Medical Technology Commercialization
Recognized for contributing to improving public health with the Company's essential products and services

SEOUL, South Korea — Nov 29, 2021 — Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, has been presented with the Korea Health Industry Development Institute (KHIDI) award for the contribution of health and medical technology commercialization. Avantor was recognized for its continuous work to help improve public health by supplying mission-critical products and services necessary for the domestic biopharmaceutical production process.

The Company supports the development of new therapies and treatments to further advance biopharma innovation by leveraging its vast global network and infrastructure, including its 11 innovation centers, notably its Avantor Korea Innovation Center.

"Everything we do at Avantor is tied to our unique mission of setting science in motion to create a better world. As such, we are very honored to win the KHIDI award for our work that promotes public health and supports the advancement of life-changing treatments and therapies. Avantor's expertise and close collaboration with biopharma manufacturers around the globe helps to address industry challenges, enabling our customers to quickly and confidently move through their research and production processes." said SangKyu Lee, Sales Director, Korea & Japan at Avantor. "Our team is grateful to the KHIDI for this recognition."

The KHIDI award is a government award event hosted by the Ministry of Health and Welfare and supervised by the Korea Health Industry Development Institute. This year's awards ceremony was held virtually on November 23, 2021.

About Avantor
Avantor@, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit and find us on Linkedln, Twitter and Facebook.

Korea Media Contact
Soomin Park
Marketing Communication Specialist, Korea
M: +82-10-3126-5339

AMEA Media Contact
Christina Koh
Director, Corporate Communications, AMEA
M: +65-9720-0169